Denali Advisors’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,700
Closed -$51.8K 505
2023
Q3
$51.8K Sell
18,700
-20,400
-52% -$62.3K 0.02% 293
2023
Q2
$123K Buy
39,100
+31,500
+414% +$114K 0.04% 253
2023
Q1
$39.6K Hold
7,600
0.02% 236
2022
Q4
$56.4K Buy
7,600
+3,900
+105% +$35.2K 0.02% 209
2022
Q3
$46K Buy
+3,700
New +$44.2K 0.02% 224

Other funds holding SRTS

Denali Advisors's SRTS Position: Q4 2023 in Review

Denali Advisors sold out of Sensus Healthcare (SRTS) in Q4 2023, closing a stake of 18,700 shares — an estimated $51.8K sold.

Denali Advisors first reported a position in SRTS in Q3 2022 and held it in 5 quarters. The position peaked at $123K in Q2 2023. 41 funds tracked by Wall St. Rank hold SRTS as of Q4 2023.

  • Denali Advisors reported no remaining Sensus Healthcare position as of Q4 2023 after selling out during the quarter.
  • Denali Advisors sold 18,700 Sensus Healthcare shares in Q4 2023, an estimated $51.8K.
  • Denali Advisors first reported a position in Sensus Healthcare in Q3 2022 and held it in 5 quarters.
  • Denali Advisors's Sensus Healthcare position peaked at $123K in Q2 2023.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2023.

Based on Denali Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.